The KEMRI-Wellcome Trust Research Program has published findings from its study on the costs of procuring and delivering the COVID-19 vaccine in Kenya. The team used an activity-based costing approach to estimate the incremental costs of COVID-19 vaccine delivery at different coverage levels from a health systems perspective. The key findings are as follows:
The financial costs of vaccine procurement per person vaccinated with two doses ranged from $2.89-$13.09 in the 30% and 100% coverage levels, respectively. The economic unit cost was $17.34 across all strategies.
The financial vaccine delivery costs per person vaccinated with two doses ranged from $4.28-$3.29 in the 30% and 100% coverage levels while the economic delivery costs were two to three times higher than the financial costs.
The total procurement and delivery costs per person vaccinated with two doses ranged from $7.34-$16.47 for the financial costs and $29.7-$24.68 for the economic costs for the 30% and 100% coverage respectively.
With the exception of procurement costs, the main cost driver of financial and economic delivery costs was supply chain costs (47-59%) and advocacy, communication, and social mobilization (29-35%), respectively. The estimated unit costs in this study also indicate possible economies of scale in COVID-19 vaccine delivery as the coverage of target populations increases.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.